Morningside Venture Investments Ltd

Average Profitability
24.52%
Insider Buys Quantity
11
Insider Buys Sum
$116.78M
Insider Sells Quantity
19
Insider Sells Sum
$3.83M

Insider Activity of Morningside Venture Investments Ltd

The largest purchase of all time was on 2020-01-13 and amounted to 1081080 shares of Apellis Pharmaceuticals, Inc. for $40M.

The largest sale of all time was on 2023-01-24 and amounted to 80000 shares of Kezar Life Sciences, Inc. for $558,400.

Biography of Morningside Venture Investments Ltd

No biography is available at this moment.

2023-02-06SaleKezar Life Sciences, Inc.
KZR
10 percent owner
40,000
0.0558%
$6.88$275,320-69.99%
2023-02-03SaleKezar Life Sciences, Inc.
KZR
10 percent owner
25,000
0.0348%
$7.15$178,650-70.14%
2023-02-02SaleKezar Life Sciences, Inc.
KZR
10 percent owner
50,000
0.0681%
$7.19$359,500-70.86%
2023-02-01SaleKezar Life Sciences, Inc.
KZR
10 percent owner
40,000
0.0558%
$6.95$278,000-68.99%
2023-01-31SaleKezar Life Sciences, Inc.
KZR
10 percent owner
30,000
0.041%
$7.08$212,400-70.01%
2023-01-30SaleKezar Life Sciences, Inc.
KZR
10 percent owner
30,000
0.041%
$6.91$207,300-68.71%
2023-01-25SaleKezar Life Sciences, Inc.
KZR
director
50,000
0.0697%
$6.85$342,500-67.35%
2023-01-24SaleKezar Life Sciences, Inc.
KZR
director
80,000
0.1103%
$6.98$558,400-68.05%
2023-01-23SaleKezar Life Sciences, Inc.
KZR
director
80,000
0.1109%
$6.81$544,800-66.76%
2023-01-17SaleKezar Life Sciences, Inc.
KZR
director
6,114
0.0088%
$6.79$41,514-64.18%
2023-01-13SaleKezar Life Sciences, Inc.
KZR
director
1,971
0.0029%
$7.15$14,093-65.5%
2023-01-12SaleKezar Life Sciences, Inc.
KZR
director
5,000
0.0068%
$6.77$33,850-65.8%
2023-01-06SaleKezar Life Sciences, Inc.
KZR
director
3,000
0.0042%
$6.89$20,670-65.2%
2023-01-05SaleKezar Life Sciences, Inc.
KZR
director
12,162
0.017%
$6.97$84,769-65.51%
2023-01-04SaleKezar Life Sciences, Inc.
KZR
director
30,000
0.0414%
$7.17$215,100-66.9%
2023-01-03SaleKezar Life Sciences, Inc.
KZR
director
500
0.0007%
$7.10$3,550-65.66%
2022-12-29SaleKezar Life Sciences, Inc.
KZR
director
25,000
0.0375%
$7.10$177,500-66.15%
2022-10-04SaleKezar Life Sciences, Inc.
KZR
director
3,612
0.0056%
$8.82$31,857-64.16%
2022-10-03SaleKezar Life Sciences, Inc.
KZR
director
28,700
0.0425%
$8.78$251,957-65.34%
2021-11-18PurchaseApellis Pharmaceuticals, Inc.
APLS
10 percent owner
500,000
0.5398%
$40.00$20M+8.88%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.